Uncategorized

Subtle Medical Announces Positive Findings from Proof-of-Concept Study with Bayer Investigating AI To Lower Gadolinium Dose in CE-MRI

PR Newswire
By PR Newswire
1 Min Read

MENLO PARK, Calif., Oct. 21, 2025 /PRNewswire/ — Subtle Medical, Inc., a leader in AI-powered medical imaging solutions, today announced positive findings from a proof-of-concept (POC) study with Bayer, a leader in Radiology, evaluating Subtle Medical’s investigational SubtleGAD™…

​MENLO PARK, Calif., Oct. 21, 2025 /PRNewswire/ — Subtle Medical, Inc., a leader in AI-powered medical imaging solutions, today announced positive findings from a proof-of-concept (POC) study with Bayer, a leader in Radiology, evaluating Subtle Medical’s investigational SubtleGAD™…  ​All Consumer Technology

Share This Article
ByPR Newswire
PR Newswire is the storytelling engine behind thousands of corporate announcements worldwide. With a rich legacy in media distribution, it helps brands turn their updates into meaningful narratives by connecting them with journalists, investors, and audiences who shape global conversations. Through trusted networks and data-backed distribution, PR Newswire ensures every story reaches the people who matter most.
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *